Regenerx Biopharmaceuticals Inc (RGRX)
0.0014
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Regenerx Biopharmaceuticals 1 Year Total Returns (Daily): -99.97% for May 16, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 16, 2024 | -99.97% |
May 15, 2024 | -99.98% |
May 14, 2024 | -99.98% |
May 13, 2024 | -99.98% |
May 10, 2024 | -99.98% |
May 09, 2024 | -99.98% |
May 08, 2024 | -99.98% |
May 07, 2024 | -99.98% |
May 06, 2024 | -99.98% |
May 03, 2024 | -99.98% |
May 02, 2024 | -99.98% |
May 01, 2024 | -99.97% |
April 30, 2024 | -99.98% |
April 29, 2024 | -99.98% |
April 26, 2024 | -99.97% |
April 25, 2024 | -99.97% |
April 24, 2024 | -99.97% |
April 23, 2024 | -99.97% |
April 22, 2024 | -99.97% |
April 19, 2024 | -99.96% |
April 18, 2024 | -99.96% |
April 17, 2024 | -99.96% |
April 16, 2024 | -98.26% |
April 15, 2024 | -98.26% |
April 12, 2024 | -98.77% |
Date | Value |
---|---|
April 11, 2024 | -99.48% |
April 10, 2024 | -99.49% |
April 09, 2024 | -99.99% |
April 08, 2024 | -99.99% |
April 05, 2024 | -99.99% |
April 04, 2024 | -99.99% |
April 03, 2024 | -99.99% |
April 02, 2024 | -99.99% |
April 01, 2024 | -99.99% |
March 28, 2024 | -99.99% |
March 27, 2024 | -99.99% |
March 26, 2024 | -99.99% |
March 25, 2024 | -99.99% |
March 22, 2024 | -99.99% |
March 21, 2024 | -99.99% |
March 20, 2024 | -99.99% |
March 19, 2024 | -99.99% |
March 18, 2024 | -99.99% |
March 15, 2024 | -99.99% |
March 14, 2024 | -99.99% |
March 13, 2024 | -99.99% |
March 12, 2024 | -99.99% |
March 11, 2024 | -99.99% |
March 08, 2024 | -99.99% |
March 07, 2024 | -99.99% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-100.00%
Minimum
Oct 23 2023
398.1%
Maximum
Sep 17 2020
-0.38%
Average
-23.81%
Median
Jul 22 2019
1 Year Total Returns (Daily) Benchmarks
FluoroPharma Medical Inc | -75.00% |
RenovaCare Inc | -97.06% |
Xeno Transplants Corp | 0.00% |
Entia Biosciences Inc | -50.00% |
OncoVista Innovative Therapies Inc | -50.00% |